← FDA Drug Approvals (Drugs@FDA)

TIGECYCLINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MEITHEAL · Approved 2021-05-13

Drug application

FDA Application #

ANDA214020

Application type

Abbreviated New Drug Application (Generic)

Brand name

TIGECYCLINE

Generic name

TIGECYCLINE

Active ingredients

TIGECYCLINE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

MEITHEAL

Manufacturer

Meitheal Pharmaceuticals Inc.

First approval

2021-05-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown